All Publications

Export 160 results:
Author Title Type [ Year(Asc)]
2014
The effects of age on associations between markers of HIV progression and markers of metabolic function including albumin, haemoglobin and lipid concentrations. Samuel M, Jose S, Winston A, Nelson M, Johnson M, Chadwick D, Fisher M, Leen C, Gompels M, Gilson R et al. HIV Med, 2014 May, Volume 15, Issue 5, p.311-6, (2014)
The contribution of viral genotype to plasma viral set-point in HIV infection. Hodcroft E, Hadfield J, Fearnhill E, Phillips A, Dunn D, O'Shea S, Pillay D and Brown A. PLoS Pathog, 2014 May, Volume 10, Issue 5, p.e1004112, (2014)
Failure to achieve a CD4+ cell count response on combination antiretroviral therapy despite consistent viral load suppression. O'Connor J, Smith C, Lampe F, Hill T, Gompels M, Hay P, Chadwick D, Fisher M, Ainsworth J, Gilson R et al. AIDS, 2014 Mar 27, Volume 28, Issue 6, p.919-24, (2014)
The increasing genetic diversity of HIV-1 in the UK, 2002-2010. . AIDS, 2014 Mar 13, Volume 28, Issue 5, p.773-80, (2014)
Response to antiretroviral therapy (ART): comparing women with previous use of zidovudine monotherapy (ZDVm) in pregnancy with ART naïve women. Huntington S, Thorne C, Anderson J, Newell M, Taylor G, Pillay D, Hill T, Tookey P and Sabin C. BMC Infect Dis, 2014 Mar 04, Volume 14, p.127, (2014)
Factors associated with short-term changes in HIV viral load and CD4(+) cell count in antiretroviral-naive individuals. . AIDS, 2014 Jun 01, Volume 28, Issue 9, p.1351-6, (2014)
Laboratory adverse events and discontinuation of therapy according to CD4(+) cell count at the start of antiretroviral therapy. Jose S, Quinn K, Hill T, Leen C, Walsh J, Hay P, Fisher M, Post F, Nelson M, Gompels M et al. AIDS, 2014 Jun 01, Volume 28, Issue 9, p.1333-9, (2014)
The emergence of drug resistant HIV variants at virological failure of HAART combinations containing efavirenz, tenofovir and lamivudine or emtricitabine within the UK Collaborative HIV Cohort. Bulteel N, Bansi-Matharu L, Churchill D, Dunn D, Bibby D, Hill T, Sabin C and Nelson M. J Infect, 2014 Jan, Volume 68, Issue 1, p.77-84, (2014)
Incomplete reversibility of estimated glomerular filtration rate decline following tenofovir disoproxil fumarate exposure. Jose S, Hamzah L, Campbell L, Hill T, Fisher M, Leen C, Gilson R, Walsh J, Nelson M, Hay P et al. J Infect Dis, 2014 Aug 01, Volume 210, Issue 3, p.363-73, (2014)
HIV-immune complex kidney disease: risk factors and progression to end-stage kidney disease Booth J, Hamzah L, Jose S, McAdoo S, Turner-Stokes T, Horsfield C, O'Donnell P, Baharani J, Kingdon E, Hendry B et al. British Renal Society Conference 2014, p.Abstract 1908 Oral, (2014)
Treatment switches following periods of low-level viraemia Jose S, Smit E, Martin F, Dunn D, Mackie N, Churchill D and Sabin C. Third Joint Conference of the British HIV Association (BHIVA) with the British Association for Sexual Health and HIV (BASHH), 2014, Volume HIV Medicine 2014; 15 (Suppl. 3), 17-159, p.Poster 156, (2014)
A comparison of virological outcomes among HIV-positive individuals receiving HAART in Canada and the UK Jose S, Chan K, Samji H, Cescon A, Hill T, Shurgold S, Phillips A, Hogg R and Sabin C. Third Joint Conference of the British HIV Association (BHIVA) with the British Association for Sexual Health and HIV (BASHH), 2014, Volume HIV Medicine 2014; 15 (Suppl. 3), 17-159, p.Poster 325, (2014)
Viral hepatitis testing patterns among HIV-positive individuals in the UK Collaborative HIV Cohort (UK CHIC) study Thornton A, Bhagani S, Burroughs A, Chadwick D, Dunn D, Fisher M, Gilson R, Jose S, Main J, Nelson M et al. Third Joint Conference of the British HIV Association (BHIVA) with the British Association for Sexual Health and HIV (BASHH), 2014, Volume HIV Medicine 2014; 15 (Suppl. 3), 17-159, p.Poster 236, (2014)
Factors associated with intervals between visits to HIV outpatient clinics Evans A, Sabin C, Apea V, Jose S, Hill T and Burns F. Third Joint Conference of the British HIV Association (BHIVA) with the British Association for Sexual Health and HIV (BASHH), 2014, Volume HIV Medicine 2014; 15 (Suppl. 3), 17-159, p.Poster 1, (2014)
Hepatitis B infection among individuals attending for care in the UK Collaborative HIV Cohort (CHIC) Study Thornton A, Bhagani S, Burroughs A, Chadwick D, Dunn D, Fisher M, Gilson R, Jose S, Main J, Rodger A et al. Third Joint Conference of the British HIV Association (BHIVA) with the British Association for Sexual Health and HIV (BASHH), 2014, Volume HIV Medicine 2014; 15 (Suppl. 3), 17-159, p.Poster 375, (2014)
End-stage kidney disease and kidney transplantation in HIV-positive patients in the UK Collaborative HIV Cohort (CHIC) study Jose S, Gathogo E, Booth C, McAdoo S, Kumar E, Rayment M, Leen C, Williams D, Post F and Sabin C. Third Joint Conference of the British HIV Association (BHIVA) with the British Association for Sexual Health and HIV (BASHH), 2014, Volume HIV Medicine 2014; 15 (Suppl. 3), 1-16, p.Oral 25, (2014)
Does pregnancy increase the risk of ART-induced hepatotoxicity among HIV-positive women? Huntington A, Thorne C, Anderson J, Newell M, Taylor G, Pillay D, Hill T, Tookey P and Sabin C. International Congress of Drug Therapy in HIV Infection, 2014, Volume J Int AIDS Soc 2014, 17(Suppl 3):19486, (2014)
Detection of NNRTI resistance mutations after interrupting NNRTI-based regimens. Cambiano V, Castro H, Chadwick D, Smit E, Geretti A, Dunn D, Phillips A and on behalf of UK HIV Drug Resistance Database and UK CHIC study. Conference on retroviruses and opportunistic infections (CROI) 2014, Volume Top Antivir Med 2014;22(e-1):291, p.Abstract 593, (2014)
Spectrum of HIV-associated kidney disease in the era of combination antiretroviral therapy. Booth J, Hamzah L, Jose S, McAdoo S, Kumar E, Horsfield C, O'Donnell P, Jones R, Sabin C and Post F. Conference on retroviruses and opportunistic infections (CROI) 2014, Volume Top Antivir Med 2014;22(e-1):410, p.Abstract 793 Poster, (2014)
End-stage kidney disease and kidney transplantation in HIV-positive patients. Gathogo E, Jose S, Booth J, McAdoo S, Kumar E, Rayment M, Leen C, Williams D, Sabin C and Post F. Conference on retroviruses and opportunistic infections (CROI) 2014, Volume Top Antivir Med 2014;22(e-1):411, p.Poster 800, (2014)
Rate of viral load failure over time in people on ART in the UK Collaborative HIV Cohort (CHIC) study O'Connor J, Smith C, Lampe F, Johnson M, Sabin C and Phillips A. International Congress of Drug Therapy in HIV Infection, 2014, Volume J Int AIDS Soc 2014, 17(Suppl 3):19527, (2014)
Predicted savings to the UK National Health Service from switching to generic antiretrovirals, 2014-2018 Hill A, Hill T, Jose S and Pozniak A. International Congress of Drug Therapy in HIV Infection, 2014, Volume J Int AIDS Soc 2014, 17(Suppl 3):19497, (2014)
Detection of resistance mutations and CD4 slopes individuals experiencing sustained virological failure Schultze A, Paredes R, Sabin C, Phillips A, Pillay D, Kirk O, Lundgren J, Pozniak A, Nelson M, Cozzi-Lepri A et al. International Congress of Drug Therapy in HIV Infection, 2014, Volume J Int AIDS Soc 2014, 17(Suppl 3):19737, (2014)
2013
The impact of HIV-1 reverse transcriptase polymorphisms on responses to first-line nonnucleoside reverse transcriptase inhibitor-based therapy in HIV-1-infected adults. Mackie N, Dunn D, Dolling D, Garvey L, Harrison L, Fearnhill E, Tilston P, Sabin C and Geretti A. AIDS, 2013 Sep 10, Volume 27, Issue 14, p.2245-53, (2013)
HLA B*5701 status, disease progression, and response to antiretroviral therapy. . AIDS, 2013 Oct 23, Volume 27, Issue 16, p.2587-92, (2013)